banner
Leukocyte membrane-modified paclitaxel-targeted sustained-release liposomes
Inquiry

Cat. No.: X26-05-ZQ2008

Leukocyte membrane-modified paclitaxel-targeted sustained-release liposomes

Synonym: Leukocyte membrane-modified paclitaxel targeted LPs; WBC membrane-camouflaged PTX sustained-release liposomes; Leukocyte membrane paclitaxel targeted sustained-release LPs

img
Product Size
100 mg; 250 mg; 500 mg; 1 g; 5 g
Price
Datasheet
MSDS
Properties
Description
This advanced biomimetic system features leukocyte membrane-modified paclitaxel-targeted sustained-release liposomes. The structural matrix incorporates the highly hydrophobic taxane diterpenoid paclitaxel directly into the hydrocarbon tail core of a high-purity phospholipid bilayer, whose exterior surface is fused with native leukocyte membrane fragments. This cellular modification introduces intact native white blood cell membrane proteins (such as integrins and cell-adhesion molecules) onto the vesicle boundary, which alters the surface charge topography, membrane elasticity, and completely prevents the passive crystallographic precipitation of the taxane cargo in open laboratory setups.
Source
Custom synthesis
Functional Group
Leukocyte membrane; Paclitaxel
Form
Solid or powder
Purity
≥95%
Impurities
No visible impurities to the naked eye.
Identity
HPLC/MS/NMR
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products

About Us

CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.

Contact Us

  • For research and manufacturing partners only. Not intended for (direct) human or veterinary use.
Copyright © CD BioGlyco. All rights reserved.